Cohen & Steers Inc. (CNS)
NYSE: CNS
· Real-Time Price · USD
76.81
1.14 (1.51%)
At close: Jun 16, 2025, 10:26 AM
1.51% (1D)
| Bid | 76.48 |
| Market Cap | 3.92B |
| Revenue (ttm) | 544.77M |
| Net Income (ttm) | 157.04M |
| EPS (ttm) | 3.06 |
| PE Ratio (ttm) | 25.1 |
| Forward PE | 21.86 |
| Analyst | Hold |
| Ask | 77.06 |
| Volume | 15,704 |
| Avg. Volume (20D) | 199,465 |
| Open | 76.75 |
| Previous Close | 75.67 |
| Day's Range | 75.67 - 77.18 |
| 52-Week Range | 68.99 - 110.67 |
| Beta | 1.32 |
Analyst Forecast
According to 0 analyst ratings, the average rating for CNS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+9.62%
Shares of capital market companies are trading hig...
Unlock content with
Pro Subscription
2 months ago
+2.6%
Shares of financial stocks are trading higher amid overall market strength on reports of potentially narrowed or targeted tariffs, which may be easing investor concerns.
1 month ago · businesswire.com
Alto Neuroscience to Participate in the JonesResearch Virtual CNS DayMOUNTAIN VIEW, Calif.--(BUSINESS WIRE)---- $ANRO #PrecisionPsychiatry--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel pre...
